Page last updated: 2024-11-04

sulfasalazine and Opportunistic Infections

sulfasalazine has been researched along with Opportunistic Infections in 3 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Research Excerpts

ExcerptRelevanceReference
"Sulfasalazine use was associated with a decreased PCP risk (adjusted IRR <0."5.91Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study. ( Chen, FY; Chinen, N; Kimura, M; Nunokawa, T; Setoguchi, K; Shimada, K; Sugihara, M; Tateishi, M, 2023)
"Sulfasalazine use was associated with a decreased PCP risk (adjusted IRR <0."1.91Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study. ( Chen, FY; Chinen, N; Kimura, M; Nunokawa, T; Setoguchi, K; Shimada, K; Sugihara, M; Tateishi, M, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Nunokawa, T1
Chinen, N1
Shimada, K1
Kimura, M1
Tateishi, M1
Chen, FY1
Setoguchi, K1
Sugihara, M1
Kniazev, OV1
Lazebnik, LB1
Parfenov, AI1
Ruchkina, IN1
Shcherbakov, PL1
Konopliannikov, AG1
Mikhaĭlova, ZF1
Khomeriki, SG1
Khatchatourian, M1
Seaton, TL1

Other Studies

3 other studies available for sulfasalazine and Opportunistic Infections

ArticleYear
Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2

    Topics: Arthritis, Rheumatoid; Humans; Methotrexate; Opportunistic Infections; Pneumocystis carinii; Pneumon

2023
[Complete elimination of cytomegalovirus without antiviral therapy after systemic mesenchymal stromal cell transplantation in a patient with ulcerative colitis (a clinical case)].
    Terapevticheskii arkhiv, 2012, Volume: 84, Issue:12

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Viral; Biopsy; Colitis, Ulcerative; Cytomegalovirus; Cy

2012
An unusual complication of immunosuppressive therapy in inflammatory bowel disease.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:9

    Topics: Aged; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antim

1997